Rod Wong: Stock Portfolio, Performance and Latest Trades
RTW Investments
13F portfolio value
$11.7B
84 holdings at Q2 2026
Get an email when Rod Wong files a new 13F report
Free, no account needed. Unsubscribe with one click.
Rod Wong's portfolio
As of Q2 2026, filed August 14, 2026 · prices as of October 8, 2026
| Company | Share of portfolio | Average buy price | Return | Current price | Last quarter |
|---|---|---|---|---|---|
| 9.14% | $231.65 | +106% | $476.91 | No change | |
Argenx SE - ADRARGX | 5.62% | $374.36 | +119% | $818.63 | No change |
| 5.39% | $38.69 | +61.7% | $62.56 | No change | |
| 5.30% | $23.88 | +486% | $139.91 | Added +0.0% | |
CG Oncology Inc.CGON | 5.16% | $53.55 | +18.1% | $63.26 | Added +22% |
Insmed Inc.INSM | 4.41% | $94.32 | +6.5% | $100.48 | No change |
| 3.71% | $13.82 | +63.4% | $22.57 | Added +4.5% | |
| 3.22% | $22.63 | +253% | $79.90 | Added +1.9% | |
Celcuity Inc.CELC | 2.95% | $105.08 | −35.4% | $67.87 | Added +8.7% |
Erasca Inc.ERAS | 2.81% | $12.39 | +24.7% | $15.46 | Added +11% |
Radnet Inc.RDNT | 2.55% | $56.22 | +21.3% | $68.21 | Added +13% |
| 2.55% | $45.19 | +71.0% | $77.28 | Added +53% | |
Natera Inc.NTRA | 2.32% | $42.81 | +813% | $390.79 | Reduced −20% |
| 2.22% | $30.77 | −50.3% | $15.29 | Added +114% | |
| 2.22% | $155.51 | −34.0% | $102.60 | Added +31% | |
| 2.08% | $31.34 | +97.9% | $62.01 | Added +5.2% | |
| 2.03% | $21.98 | −54.5% | $10.00 | New | |
| 1.95% | $28.75 | +111% | $60.61 | No change | |
| 1.90% | $48.77 | +239% | $165.56 | No change | |
| 1.82% | $120.15 | +17.6% | $141.25 | Added +19% | |
| 1.80% | $28.50 | +153% | $72.22 | Added +0.3% | |
| 1.57% | $24.22 | −1.1% | $23.95 | No change | |
Uniqure NVQURE | 1.55% | $25.38 | −11.2% | $22.54 | Added +52% |
| 1.54% | $21.24 | −7.8% | $19.58 | No change | |
Repligen Corp.RGEN | 1.45% | $153.75 | +6.6% | $163.84 | Added +2.9% |
| 1.43% | $14.93 | +148% | $36.98 | No change | |
GH Research PLCGHRS | 1.36% | $15.27 | +33.9% | $20.45 | No change |
| 1.32% | $41.85 | −30.5% | $29.09 | No change | |
| 1.29% | $4.52 | +154% | $11.47 | Added +0.6% | |
Immatics NVIMTX | 1.12% | $10.00 | −26.3% | $7.37 | Added +0.6% |
Zai Lab Ltd-AdrZLAB | 1.07% | $25.69 | −3.4% | $24.81 | No change |
Immunovant Inc.IMVT | 1.05% | $22.30 | +35.7% | $30.26 | No change |
| 0.94% | $95.37 | +59.9% | $152.52 | No change | |
Xencor Inc.XNCR | 0.93% | $13.91 | +76.2% | $24.50 | No change |
| 0.79% | $2.28 | +94.5% | $4.43 | Reduced −0.9% | |
| 0.76% | $24.71 | +21.7% | $30.08 | Reduced −58% | |
Alkermes PLCALKS | 0.75% | $27.15 | +47.7% | $40.11 | No change |
| 0.74% | $44.24 | −42.0% | $25.67 | New | |
| 0.70% | $6.32 | +106% | $13.04 | Added +0.7% | |
| 0.57% | $32.29 | +4.4% | $33.71 | Added +0.7% | |
| 0.56% | $5.44 | +77.5% | $9.66 | No change | |
| 0.52% | $17.00 | −84.5% | $2.63 | No change | |
| 0.49% | $20.48 | +360% | $94.26 | No change | |
| 0.44% | $19.42 | −8.6% | $17.74 | No change | |
Axogen Inc.AXGN | 0.40% | $40.32 | −10.3% | $36.18 | New |
| 0.37% | $181.57 | +19.8% | $217.46 | New | |
| 0.37% | $18.52 | −16.5% | $15.46 | Added +39% | |
Neurogene Inc.NGNE | 0.37% | $32.23 | −17.8% | $26.50 | No change |
| 0.35% | $42.77 | +129% | $98.00 | Reduced −74% | |
| 0.35% | $9.33 | −38.6% | $5.73 | Added +15% | |
| 0.33% | $7.58 | −10.0% | $6.82 | New | |
Savara Inc.SVRA | 0.31% | $4.90 | −1.4% | $4.83 | No change |
| 0.26% | $4.28 | +11.2% | $4.76 | No change | |
| 0.23% | $67.53 | +61.9% | $109.30 | No change | |
Verastem Inc.VSTM | 0.22% | $6.82 | +18.9% | $8.11 | Added +0.9% |
| 0.21% | $57.91 | +42.3% | $82.43 | No change | |
| 0.20% | $18.64 | −6.5% | $17.43 | Reduced −25% | |
| 0.18% | $2.10 | −30.6% | $1.46 | No change | |
Evommune Inc.EVMN | 0.17% | $19.40 | −67.0% | $6.41 | No change |
| 0.17% | $25.51 | −3.6% | $24.60 | No change | |
| 0.16% | $18.91 | +80.8% | $34.18 | Added +33% | |
| 0.12% | $30.61 | +17.8% | $36.06 | New | |
Ataibeckley Inc.04650F101 | 0.09% | $3.54 | — | — | No change |
| 0.09% | $7.17 | −90.1% | $0.712 | Added +24% | |
Ocugen Inc.OCGN | 0.09% | $1.73 | −43.5% | $0.977 | No change |
| 0.09% | $9.39 | — | — | Added +88% | |
Heartflow Inc.HTFL | 0.07% | $32.24 | +47.7% | $47.63 | Reduced −40% |
Freenome Inc.FRNM | 0.07% | $10.06 | +57.2% | $15.81 | No change |
Wave Life Sciences Ltd.Y95308105 | 0.07% | $11.13 | — | — | No change |
| 0.07% | $3.84 | −29.7% | $2.70 | Added +71% | |
| 0.06% | $18.50 | −44.2% | $10.33 | No change | |
| 0.06% | $2.20 | −36.3% | $1.40 | New | |
| 0.06% | $12.74 | +10.8% | $14.12 | No change | |
| 0.05% | $10.14 | +25.2% | $12.70 | No change | |
| 0.05% | $26.21 | −1.3% | $25.88 | New | |
| 0.05% | $28.86 | −72.2% | $8.01 | No change | |
| 0.05% | $6.39 | −60.9% | $2.50 | No change | |
Abivax Sa-AdrABVX | 0.03% | $133.26 | −33.2% | $89.05 | New |
| 0.03% | $15.64 | −14.1% | $13.43 | Reduced −80% | |
| 0.02% | $42.00 | −14.9% | $35.74 | No change | |
| 0.02% | $84.50 | −28.1% | $60.77 | No change | |
| 0.02% | $13.25 | −67.9% | $4.26 | No change | |
Exagen Inc.XGN | 0.01% | $11.02 | −25.8% | $8.17 | Reduced −51% |
Rocket Pharmaceuticals In-2777313F114 | 0.00% | $0.11 | — | — | No change |
Rod Wong's buys and sells
| Company | Action | Shares change | Value now |
|---|---|---|---|
Avidity Biosciences Inc.05370A108 | Sold out | −11,372,829 | — |
Insmed Inc.INSM | Added +57% | +1,758,321 | $842.9M |
Akero Therapeutics Inc.00973Y108 | Sold out | −5,477,561 | — |
| Added +119% | +4,124,755 | $269.7M | |
| New | +1,181,990 | $209.7M | |
Apellis Pharmaceuticals03753U106 | New | +7,666,764 | $192.6M |
Merus NVN5749R100 | Sold out | −2,025,277 | — |
Repligen Corp.RGEN | New | +1,064,000 | $174.3M |
Uniqure NVQURE | Reduced −16% | −713,506 | $88.8M |
| Reduced −50% | −245,000 | $86.1M | |
| New | +324,600 | $92.3M | |
| Added +129% | +402,832 | $114.4M | |
| Added +5.0% | +157,884 | $273.1M | |
| New | +2,115,237 | $82.3M | |
Immunovant Inc.IMVT | New | +3,177,850 | $80.8M |
| Added +15% | +550,000 | $136.7M | |
Radnet Inc.RDNT | Added +40% | +1,122,956 | $281M |
| Reduced −12% | −697,224 | $441.9M | |
| Added +8.3% | +423,331 | $176.1M | |
Celcuity Inc.CELC | New | +550,160 | $54.9M |
| Sold out | −250,000 | — | |
Zai Lab Ltd-AdrZLAB | Added +204% | +4,667,660 | $122.8M |
Immatics NVIMTX | Added +30% | +2,617,737 | $120.1M |
| Added +12% | +744,620 | $69.4M | |
| New | +1,487,933 | $41.6M | |
| Sold out | −863,389 | — | |
| New | +584,716 | $38.8M | |
| Sold out | −2,890,567 | — | |
Savara Inc.SVRA | New | +5,952,380 | $35.9M |
| Reduced −50% | −101,228 | $57.3M | |
Xencor Inc.XNCR | Added +8.9% | +556,407 | $103.8M |
Abivax Sa-AdrABVX | Sold out | −350,000 | — |
| Sold out | −393,500 | — | |
| Reduced −7.9% | −258,127 | $69M | |
Crinetics Pharmaceuticals In22663K107 | Added +55% | +478,939 | $62.9M |
| Reduced −21% | −230,882 | $162.2M | |
| Added +5.8% | +112,499 | $62.4M | |
Evommune Inc.EVMN | New | +1,283,671 | $22M |
Natera Inc.NTRA | Reduced −25% | −500,000 | $343.6M |
Alector Inc.ALEC | Sold out | −6,990,806 | — |
| New | +240,000 | $18.7M | |
| New | +705,027 | $18.5M | |
| Added +11% | +166,666 | $55.5M | |
| New | +353,500 | $16.4M | |
Wave Life Sciences Ltd.Y95308105 | Added +50% | +450,000 | $23M |
| Reduced −83% | −2,231,872 | $3.4M | |
| New | +570,394 | $15.8M | |
CG Oncology Inc.CGON | Added +18% | +310,911 | $83.5M |
Exagen Inc.XGN | Reduced −53% | −906,404 | $4.8M |
| New | +1,491,228 | $13.2M | |
| New | +650,000 | $12M | |
| Sold out | −3,461,500 | — | |
| New | +1,300,000 | $11M | |
Centessa Pharmaceuticals-Adr152309100 | Reduced −22% | −500,910 | $44.8M |
| Reduced −24% | −799,191 | $76.2M | |
| Reduced −33% | −7,955,994 | $90.2M | |
| Added +0.6% | +50,000 | $60.4M | |
| New | +46,000 | $10.4M | |
Ataibeckley Inc.N0731H103 | New | +2,000,000 | $8.2M |
| New | +250,000 | $7.2M | |
| New | +100,000 | $7M | |
Pepgen Inc.PEPG | Sold out | −1,500,000 | — |
| New | +1,298,701 | $6M | |
| New | +372,856 | $4.4M | |
GH Research PLCGHRS | Added +6.5% | +364,251 | $75.4M |
Mind Medicine Mindmed Inc.60255C885 | New | +300,000 | $4M |
| New | +475,737 | $3.6M | |
| New | +70,000 | $2.9M | |
Verastem Inc.VSTM | Added +21% | +1,150,000 | $50.8M |
| New | +30,000 | $2.4M | |
Allurion Technologies-2802008G201 | Added +132% | +3,348,827 | $7.2M |
Erasca Inc.ERAS | New | +146,651 | $545.5K |
| Sold out | −209,361 | — |
Rod Wong's portfolio by sector
Share of the stock portfolio at Q2 2026.
| Sector | Share |
|---|---|
| Health Care | 99% |
| Technology | 0.7% |
| Other | 0.2% |
Portfolio performance: Rod Wong vs. benchmarks
Your result if you had bought each reported portfolio on the day it was made public and held it until the next report, against the S&P 500 and Nasdaq-100.
- You, copying after each 13F filing – estimated value
- S&P 500
- Nasdaq-100
| Total return | Per year | |
|---|---|---|
| You, copying after each 13F filing – estimated value | −4.1% | −0.8% |
| S&P 500 | +89.0% | +13.6% |
| Nasdaq-100 | +113.3% | +16.4% |
Prices were available for 66% of the portfolio value on average; the rest is left out of the return.
Rod Wong's most traded stocks
Quarters with a buy or a sell, all reports since Q4 2014.
| Company | Quarters bought | Quarters sold |
|---|---|---|
| 21 | 7 | |
Regenxbio Inc.RGNX | 19 | 9 |
| 17 | 11 | |
| 23 | 4 | |
| 15 | 11 | |
| 16 | 10 | |
| 18 | 7 | |
| 20 | 5 | |
| 16 | 8 | |
Natera Inc.NTRA | 16 | 6 |
| 15 | 7 | |
Argenx SE - ADRARGX | 20 | 2 |
Uniqure NVQURE | 15 | 6 |
Vericel Corp.VCEL | 12 | 8 |
Exagen Inc.XGN | 13 | 6 |